Lyophilisation for Pharmaceuticals Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4136641
- 109 Pages
- December 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Lyophilisation for Pharmaceuticals market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Lyophilisation for Pharmaceuticals market segmented into
CGMP lyophilisers
Laboratory lyophilisers
Lyophilisation services
Others
Based on the end-use, the global Lyophilisation for Pharmaceuticals market classified into
Therapeutic monoclonal antibodies (mAbs)
Insulins
Interferons
Other recombinant hormones
Plasma and recombinant coagulation factors
Biosimilars
Vaccines
Others
Based on geography, the global Lyophilisation for Pharmaceuticals market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
SP Scientific
GEA Lyophil GmbH
Labconco Corporation
IIShinBioBase
IMA Life
Martin Christ Gefriertrocknungsanlagen GmbH
Boehringer Ingelheim BioXcellence
Pantheon
Baxter BioPharma Solutions
Recipharm
IDT Biologika GmbH
Vetter Pharma-Fertigung
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL LYOPHILISATION FOR PHARMACEUTICALS INDUSTRY
2.1 Summary about Lyophilisation for Pharmaceuticals Industry
2.2 Lyophilisation for Pharmaceuticals Market Trends
2.2.1 Lyophilisation for Pharmaceuticals Production & Consumption Trends
2.2.2 Lyophilisation for Pharmaceuticals Demand Structure Trends
2.3 Lyophilisation for Pharmaceuticals Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 CGMP lyophilisers
4.2.2 Laboratory lyophilisers
4.2.3 Lyophilisation services
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Therapeutic monoclonal antibodies (mAbs)
4.3.2 Insulins
4.3.3 Interferons
4.3.4 Other recombinant hormones
4.3.5 Plasma and recombinant coagulation factors
4.3.6 Biosimilars
4.3.7 Vaccines
4.3.8 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 CGMP lyophilisers
5.2.2 Laboratory lyophilisers
5.2.3 Lyophilisation services
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Therapeutic monoclonal antibodies (mAbs)
5.3.2 Insulins
5.3.3 Interferons
5.3.4 Other recombinant hormones
5.3.5 Plasma and recombinant coagulation factors
5.3.6 Biosimilars
5.3.7 Vaccines
5.3.8 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 CGMP lyophilisers
6.2.2 Laboratory lyophilisers
6.2.3 Lyophilisation services
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Therapeutic monoclonal antibodies (mAbs)
6.3.2 Insulins
6.3.3 Interferons
6.3.4 Other recombinant hormones
6.3.5 Plasma and recombinant coagulation factors
6.3.6 Biosimilars
6.3.7 Vaccines
6.3.8 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 CGMP lyophilisers
7.2.2 Laboratory lyophilisers
7.2.3 Lyophilisation services
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Therapeutic monoclonal antibodies (mAbs)
7.3.2 Insulins
7.3.3 Interferons
7.3.4 Other recombinant hormones
7.3.5 Plasma and recombinant coagulation factors
7.3.6 Biosimilars
7.3.7 Vaccines
7.3.8 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 CGMP lyophilisers
8.2.2 Laboratory lyophilisers
8.2.3 Lyophilisation services
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Therapeutic monoclonal antibodies (mAbs)
8.3.2 Insulins
8.3.3 Interferons
8.3.4 Other recombinant hormones
8.3.5 Plasma and recombinant coagulation factors
8.3.6 Biosimilars
8.3.7 Vaccines
8.3.8 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 CGMP lyophilisers
9.2.2 Laboratory lyophilisers
9.2.3 Lyophilisation services
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Therapeutic monoclonal antibodies (mAbs)
9.3.2 Insulins
9.3.3 Interferons
9.3.4 Other recombinant hormones
9.3.5 Plasma and recombinant coagulation factors
9.3.6 Biosimilars
9.3.7 Vaccines
9.3.8 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 SP Scientific
10.1.2 GEA Lyophil GmbH
10.1.3 Labconco Corporation
10.1.4 IIShinBioBase
10.1.5 IMA Life
10.1.6 Martin Christ Gefriertrocknungsanlagen GmbH
10.1.7 Boehringer Ingelheim BioXcellence
10.1.8 Pantheon
10.1.9 Baxter BioPharma Solutions
10.1.10 Recipharm
10.1.11 IDT Biologika GmbH
10.1.12 Vetter Pharma-Fertigung
10.2 Lyophilisation for Pharmaceuticals Sales Date of Major Players (2017-2020e)
10.2.1 SP Scientific
10.2.2 GEA Lyophil GmbH
10.2.3 Labconco Corporation
10.2.4 IIShinBioBase
10.2.5 IMA Life
10.2.6 Martin Christ Gefriertrocknungsanlagen GmbH
10.2.7 Boehringer Ingelheim BioXcellence
10.2.8 Pantheon
10.2.9 Baxter BioPharma Solutions
10.2.10 Recipharm
10.2.11 IDT Biologika GmbH
10.2.12 Vetter Pharma-Fertigung
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
Table Lyophilisation for Pharmaceuticals Product Type Overview
Table Lyophilisation for Pharmaceuticals Product Type Market Share List
Table Lyophilisation for Pharmaceuticals Product Type of Major Players
Table Brief Introduction of SP Scientific
Table Brief Introduction of GEA Lyophil GmbH
Table Brief Introduction of Labconco Corporation
Table Brief Introduction of IIShinBioBase
Table Brief Introduction of IMA Life
Table Brief Introduction of Martin Christ Gefriertrocknungsanlagen GmbH
Table Brief Introduction of Boehringer Ingelheim BioXcellence
Table Brief Introduction of Pantheon
Table Brief Introduction of Baxter BioPharma Solutions
Table Brief Introduction of Recipharm
Table Brief Introduction of IDT Biologika GmbH
Table Brief Introduction of Vetter Pharma-Fertigung
Table Products & Services of SP Scientific
Table Products & Services of GEA Lyophil GmbH
Table Products & Services of Labconco Corporation
Table Products & Services of IIShinBioBase
Table Products & Services of IMA Life
Table Products & Services of Martin Christ Gefriertrocknungsanlagen GmbH
Table Products & Services of Boehringer Ingelheim BioXcellence
Table Products & Services of Pantheon
Table Products & Services of Baxter BioPharma Solutions
Table Products & Services of Recipharm
Table Products & Services of IDT Biologika GmbH
Table Products & Services of Vetter Pharma-Fertigung
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Lyophilisation for Pharmaceuticals Market Forecast (Million USD) by Region 2021f-2026f
Table Global Lyophilisation for Pharmaceuticals Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Lyophilisation for Pharmaceuticals Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Lyophilisation for Pharmaceuticals Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
